PMID- 28817123 OWN - NLM STAT- MEDLINE DCOM- 20170830 LR - 20201207 IS - 1750-2799 (Electronic) IS - 1754-2189 (Print) IS - 1750-2799 (Linking) VI - 12 IP - 9 DP - 2017 Sep TI - Evaluation of telomere length in human cardiac tissues using cardiac quantitative FISH. PG - 1855-1870 LID - 10.1038/nprot.2017.082 [doi] AB - Telomere length has been correlated with various diseases, including cardiovascular disease and cancer. The use of currently available telomere-length measurement techniques is often restricted by the requirement of a large amount of cells (Southern-based techniques) or the lack of information on individual cells or telomeres (PCR-based methods). Although several methods have been used to measure telomere length in tissues as a whole, the assessment of cell-type-specific telomere length provides valuable information on individual cell types. The development of fluorescence in situ hybridization (FISH) technologies enables the quantification of telomeres in individual chromosomes, but the use of these methods is dependent on the availability of isolated cells, which prevents their use with fixed archival samples. Here we describe an optimized quantitative FISH (Q-FISH) protocol for measuring telomere length that bypasses the previous limitations by avoiding contributions from undesired cell types. We have used this protocol on small paraffin-embedded cardiac-tissue samples. This protocol describes step-by-step procedures for tissue preparation, permeabilization, cardiac-tissue pretreatment and hybridization with a Cy3-labeled telomeric repeat complementing (CCCTAA)(3) peptide nucleic acid (PNA) probe coupled with cardiac-specific antibody staining. We also describe how to quantify telomere length by means of the fluorescence intensity and area of each telomere within individual nuclei. This protocol provides comparative cell-type-specific telomere-length measurements in relatively small human cardiac samples and offers an attractive technique to test hypotheses implicating telomere length in various cardiac pathologies. The current protocol (from tissue collection to image procurement) takes approximately 28 h along with three overnight incubations. We anticipate that the protocol could be easily adapted for use on different tissue types. FAU - Sharifi-Sanjani, Maryam AU - Sharifi-Sanjani M AD - Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. FAU - Meeker, Alan K AU - Meeker AK AD - Departments of Pathology, Oncology and Urology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. FAU - Mourkioti, Foteini AU - Mourkioti F AUID- ORCID: 0000-0002-7119-6640 AD - Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, Pennsylvania, USA. AD - Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. AD - Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. LA - eng GR - P30 AR069619/AR/NIAMS NIH HHS/United States PT - Journal Article DEP - 20170817 PL - England TA - Nat Protoc JT - Nature protocols JID - 101284307 RN - 0 (Carbocyanines) RN - 0 (Peptide Nucleic Acids) RN - 0 (cyanine dye 3) SB - IM MH - Carbocyanines/chemistry MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - Myocardium/*chemistry MH - Peptide Nucleic Acids/chemistry MH - Telomere/*chemistry PMC - PMC7716275 MID - NIHMS1646107 EDAT- 2017/08/18 06:00 MHDA- 2017/08/31 06:00 PMCR- 2020/12/04 CRDT- 2017/08/18 06:00 PHST- 2017/08/18 06:00 [entrez] PHST- 2017/08/18 06:00 [pubmed] PHST- 2017/08/31 06:00 [medline] PHST- 2020/12/04 00:00 [pmc-release] AID - nprot.2017.082 [pii] AID - 10.1038/nprot.2017.082 [doi] PST - ppublish SO - Nat Protoc. 2017 Sep;12(9):1855-1870. doi: 10.1038/nprot.2017.082. Epub 2017 Aug 17.